Blood Cancer
EA4232 / PTCL-STAT
A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients with Peripheral T Cell Lymphoma that Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)
Physician and Research Staff Educational Material
This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.
Physician Fact Sheet
Patient Educational Material
Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material.
Patient Video
Study Chair Dr. Nora Bennani of the Mayo Clinic discusses this study that is testing a new treatment approach for patients with peripheral T-cell lymphoma who are in remission after initial therapy.
